Real-World Persistence, Adherence, Hypoglycemia, and Health Care Resource Utilization in People With Type 2 Diabetes Who Continued With the Second-Generation Basal Insulin Analog Insulin Glargine 300 Units/mL or Switched to a First-Generation Basal Insulin (Insulin Glargine 100 Units/mL or Detemir 100)

People with type 2 diabetes receiving a second-generation basal insulin (BI) analog may be switched to a first-generation formulation for financial reasons or changes in health insurance. However, because second-generation BI analogs have more even pharmacokinetic profiles, longer durations of actio...

Descripción completa

Detalles Bibliográficos
Autores principales: Edelman, Steven, Goldman, Jennifer, Malone, Daniel C., Preblick, Ronald, Munaga, Kovida, Li, Xuan, Gill, Jasvinder, Gangi, Sumana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2023
Materias:
Feature Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338281/
https://www.ncbi.nlm.nih.gov/pubmed/37456096
http://dx.doi.org/10.2337/cd22-0096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338281/
https://www.ncbi.nlm.nih.gov/pubmed/37456096
http://dx.doi.org/10.2337/cd22-0096

Ejemplares similares